DS
Therapeutic Areas
Anapole Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RGFields for HIV | HIV | Clinical (phase unspecified) |
| RGFields for Tuberculosis | Tuberculosis | Pre-clinical |
| RGFields for Oncology | Aggressive Cancers (e.g., Glioblastoma) | Pre-clinical |
Leadership Team at Anapole Technologies
SF
Stephen F. Botsford
Chief Executive Officer, Chairman of the Board
J(
Joseph (Jodi) Startari
President, Board of Directors, Founder
SF
Stephen F. Botsford, Jr.
Board of Directors, Treasurer/Secretary
DA
Damian Antonescu
Manager, Investor Relations